DBV TECHNOLOGIES (EPA:DBV) | Finanzwire

Basculer en Français

9478	Companies
185492	Keywords
117871	Articles
99349	Press releases

Home
Companies
DBV TECHNOLOGIES

PRESS RELEASE

published on 05/05/2025 at 22:30, 6 months 30 days ago

DBV Technologies to Participate in the Citizens JMP Life Sciences Conference
DBV Technologies CEO to speak at Citizens JMP Life Sciences Conference in NY. Company develops treatments for food allergies with VIASKIN patch technology

DBV Technologies Food Allergies VIASKIN Patch Life Sciences Conference Citizens JMP
BRIEF

published on 04/15/2025 at 14:16, 7 months 20 days ago

Baker Bros Advisors Crosses Thresholds at DBV Technologies

Warrants Capital Increase Threshold Crossing DBV Technologies Baker Bros Advisors
BRIEF

published on 04/15/2025 at 14:13, 7 months 20 days ago

JP Morgan Chase & Co. Crosses Thresholds in DBV Technologies

Financial Market Threshold Crossing Shares And Voting Rights DBV Technologies JP Morgan Chase & Co.
BRIEF

published on 04/11/2025 at 22:35, 7 months 23 days ago

DBV Technologies Releases Annual Financial Reports

Biopharmaceutical Company Universal Registration Document Form 10-K DBV Technologies 2024 Financial Statements
PRESS RELEASE

published on 04/11/2025 at 22:30, 7 months 23 days ago

DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document
DBV Technologies files 2024 Annual Report on Form 10-K and Universal Registration Document, providing financial updates and corporate governance details

Financial Updates Universal Registration Document Form 10-K DBV Technologies 2024 Annual Report
BRIEF

published on 04/04/2025 at 11:22, 8 months 1 day ago

Crossing thresholds at DBV Technologies

Capital Actions Threshold Crossing DBV Technologies Syquant Capital
PRESS RELEASE

published on 03/28/2025 at 03:30, 8 months 8 days ago

DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
DBV Technologies secures financing of up to $306.9 million (€284.5 million) to advance Viaskin Peanut Patch through FDA submission and US commercial launch. Investors include MPM BioImpact, Adage Capital Management, Janus Henderson Investors, and more

Financing Commercial Launch DBV Technologies FDA Submission Viaskin Peanut Patch
BRIEF

published on 03/24/2025 at 07:35, 8 months 12 days ago

DBV Technologies Anticipates Regulatory Progress with the FDA

FDA Agreement DBV Technologies Viaskin Peanut Treasury 2024 SPEED Study
PRESS RELEASE

published on 03/24/2025 at 07:30, 8 months 12 days ago

DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
DBV Technologies secures FDA agreement for Viaskin Peanut Patch BLA submission in 4-7-year-olds, accelerating launch timeline by approximately one year. Unaudited 2024 financial results reported

FDA Agreement DBV Technologies Unaudited Financial Results Viaskin Peanut Patch BLA Submission
BRIEF

published on 02/25/2025 at 22:06, 9 months 7 days ago

DBV Technologies at AAAAI/WAO Congress to Present Advances in Peanut Allergy

Clinical Study DBV Technologies Peanut Allergy AAAAI/WAO Congress VIASKIN® Patch

Accesswire

Published on 12/05/2025 at 16:00, 35 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 50 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 1 hour ago

XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:25, 1 hour 10 minutes ago

Usha Resources Provides Corporate Updates
Published on 12/05/2025 at 15:00, 1 hour 35 minutes ago

Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 16:25, 10 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 25 minutes ago

Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 35 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 35 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 16:00, 35 minutes ago

Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025

Les Echos

Published on 12/05/2025 at 15:10, 1 hour 24 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 7 hours 50 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 22 hours 35 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 22 hours 50 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 22 hours 51 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution

View all LES ECHOS COMFI WIRE